LoVE4MUM Mobile App to Prevent Postpartum Depression: Protocol for a Pilot Randomized Controlled Trial
- PMID: 39869891
- PMCID: PMC11811676
- DOI: 10.2196/63564
LoVE4MUM Mobile App to Prevent Postpartum Depression: Protocol for a Pilot Randomized Controlled Trial
Abstract
Background: Postpartum depression remains a significant concern, posing substantial challenges to maternal well-being, infant health, and the mother-infant bond, particularly in the face of barriers to traditional support and interventions. Previous studies have shown that mobile health (mHealth) interventions offer an accessible means to facilitate early detection and management of mental health issues while at the same time promoting preventive care.
Objective: This study aims to evaluate the effectiveness of the Leveraging on Virtual Engagement for Maternal Understanding & Mood-enhancement (LoVE4MUM) mobile app, which was developed based on the principles of cognitive behavioral therapy and psychoeducation and serves as an intervention to prevent postpartum depression.
Methods: This single-blinded, pilot randomized controlled trial includes 64 mothers recruited from the postnatal ward and randomized using a 1:1 ratio to receive either postpartum care (treatment as usual) or postpartum care (treatment as usual) plus the self-guided LoVE4MUM mobile app. The primary outcome is the effectiveness of the mobile app at improving postpartum depression. Secondary outcomes are changes in the mental health literacy score and negative automatic thoughts, which are collected using a self-reported questionnaire.
Results: Patient recruitment began on September 1, 2024. As of January 1, 2025, recruitment was successfully completed, with a total of 72 participants enrolled: 36 in the intervention group and 36 in the control group . The final results are anticipated to be available by March 2025, and publication is expected by the end of 2025.
Conclusions: By examining the LoVE4MUM app alongside standard postpartum care, this pilot randomized controlled trial seeks to offer preliminary evidence on the potential of mHealth tools to improve maternal mental health as well as to reduce postpartum depression symptoms. The findings are expected to contribute to the future development of effective, accessible, and scalable interventions for mothers.
Trial registration: ClinicalTrials.gov NCT06366035; https://clinicaltrials.gov/study/NCT06366035.
International registered report identifier (irrid): PRR1-10.2196/63564.
Keywords: depression; engagement; mHealth intervention; maternal; mental health literacy; mobile app; mobile health; mobile phone; postpartum; postpartum care; postpartum depression; prevention; preventive care; protocol; randomized controlled trial; self-guided; virtual engagement; well-being.
©Siti Sabrina Kamarudin, Idayu Badilla Idris, Shalisah Sharip, Norfazilah Ahmad. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 27.01.2025.
Conflict of interest statement
Conflicts of Interest: None declared.
Similar articles
-
A study protocol of mobile phone app-based cognitive behaviour training for the prevention of postpartum depression among high-risk mothers.BMC Public Health. 2019 Jun 7;19(1):710. doi: 10.1186/s12889-019-6941-8. BMC Public Health. 2019. PMID: 31174494 Free PMC article.
-
Mobile App Promoting Resilience in Stress Management for Adolescents and Young Adults With Cancer: Protocol for a Pilot Randomized Controlled Trial.JMIR Res Protoc. 2024 Jul 30;13:e57950. doi: 10.2196/57950. JMIR Res Protoc. 2024. PMID: 39079108 Free PMC article.
-
Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC).JMIR Res Protoc. 2022 Nov 25;11(11):e40817. doi: 10.2196/40817. JMIR Res Protoc. 2022. PMID: 36427227 Free PMC article.
-
Impact of mobile health interventions during the perinatal period on maternal psychosocial outcomes: a systematic review.JBI Evid Synth. 2020 Jan;18(1):30-55. doi: 10.11124/JBISRIR-D-19-00191. JBI Evid Synth. 2020. PMID: 31972680
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
References
-
- Chen Q, Li W, Xiong J, Zheng X. Prevalence and risk factors associated with postpartum depression during the COVID-19 pandemic: a literature review and meta-analysis. Int J Environ Res Public Health. 2022 Feb 16;19(4):A. doi: 10.3390/ijerph19042219. https://www.mdpi.com/resolver?pii=ijerph19042219 ijerph19042219 - DOI - PMC - PubMed
-
- Fact sheet: National Health and Morbidity Survey 2022: maternal and child health (MCH) Institute for Public Health (IKU), National Institute of Health (NIH) [2025-01-01]. https://iku.gov.my/images/nhms-2022/5a.-fact-sheet-nhms-mch-english.pdf?... .
-
- Martinez-Torteya C, Katsonga-Phiri T, Rosenblum KL, Hamilton L, Muzik M. Postpartum depression and resilience predict parenting sense of competence in women with childhood maltreatment history. Arch Womens Ment Health. 2018 Dec 2;21(6):777–784. doi: 10.1007/s00737-018-0865-7. https://europepmc.org/abstract/MED/29860623 10.1007/s00737-018-0865-7 - DOI - PMC - PubMed
-
- Shi P, Ren H, Li H, Dai Q. Maternal depression and suicide at immediate prenatal and early postpartum periods and psychosocial risk factors. Psychiatry Res. 2018 Mar;261:298–306. doi: 10.1016/j.psychres.2017.12.085. https://pubmed.ncbi.nlm.nih.gov/29331710/ S0165-1781(16)31888-1 - DOI - PubMed
-
- Arifin S, Cheyne H, Maxwell M, Yousuf A. The Malaysian women's experience of care and management of postnatal depression. Clin Pract Epidemiol Ment Health. 2021;17:10–18. doi: 10.2174/1745017902117010010. https://europepmc.org/abstract/MED/34040649 CPEMH-17-10 - DOI - PMC - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous